![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/METROPOLIS.png)
Share the post "Metropolis Healthcare ‘s Q3 2024-25 Latest News: Revenue Grows by 10.87% YoY"
Highlights
🔹 The presented financial data is Consolidated to provide a comprehensive overview of the company performance. 🔹 Sales over the Year and quarter: The company experienced a substantial growth of 10.87 % in the past year, decrease in net sales/revenue by -7.73 %. 🔹 Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 10.84 %. Marginal decrease of -18.31% in other income during this quarter. 🔹 Profit over the Year and quarter: Significant improvement in profitability for Metropolis Healthcare Limited. Notable increase of 15.34 % in net profit Year to Year, Metropolis Healthcare Limited’s profitability dropped by -32.6 % Quarter to Quarter. 🔹 EPS over the Year and quarter: EPS increased by 15.28 % Year to Year. EPS decreased by -32.71 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 291.117 Cr | Rs. 349.789 Cr | Rs. 322.767 Cr | -7.73 % | + 10.87 % |
| Expenses | Rs. 226.27 Cr | Rs. 259.91 Cr | Rs. 250.76 Cr | -3.52 % | + 10.82 % |
| Operating Profit | Rs. 64.85 Cr | Rs. 89.88 Cr | Rs. 72.01 Cr | -19.88 % | + 11.04 % |
| OPM % | 22.28 % | 25.7 % | 22.31 % | -3.39 % | + 0.03 % |
| Other Income | Rs. 2.306 Cr | Rs. 3.129 Cr | Rs. 2.556 Cr | -18.31 % | + 10.84 % |
| Interest | Rs. 5.31 Cr | Rs. 4.79 Cr | Rs. 4.53 Cr | -5.43 % | -14.69 % |
| Depreciation | Rs. 24.99 Cr | Rs. 26.82 Cr | Rs. 27.7 Cr | + 3.28 % | + 10.84 % |
| Profit before tax | Rs. 36.86 Cr | Rs. 61.4 Cr | Rs. 42.34 Cr | -31.04 % | + 14.87 % |
| Tax % | 25.96 % | 23.94 % | 25.65 % | + 1.71 % | -0.31 % |
| Net Profit | Rs. 27.29 Cr | Rs. 46.7 Cr | Rs. 31.48 Cr | -32.59 % | + 15.35 % |
| EPS in Rs | Rs. 5.28 | Rs. 9.03 | Rs. 6.09 | -32.56 % | + 15.34 % |
Today, we’re looking at Metropolis Healthcare Limited’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 10.87 %. However, it did see a marginal slip of -7.73 % from the previous quarter. Expenses decreased slightly by -3.52 % quarter-on-quarter, aligning with the annual rise of 10.82 %. Operating profit, while up 11.04 % compared to last year, faced a quarter-on-quarter dip of -19.88 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 0.03 %, but a shrinkage of -3.39 % sequentially. Other income fell by -18.31 % compared to the last quarter, despite an annual growth of 10.84 %. Interest expenses dropped significantly by -5.43 % from the previous quarter, yet the year-over-year decrease remains at a moderate -14.69 %. Depreciation costs climbed by 3.28 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 10.84 %. Profit before tax grew annually by 14.87 % but saw a reduction from the preceding quarter by -31.04 %.
Tax expenses as a percentage of profits decreased slightly by -0.31 % compared to last year, with a more notable quarter-on-quarter increase of 1.71 %. Net profit rose by 15.35 % year-on-year but witnessed a -32.59 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 15.34 % but a quarterly fall of -32.56 %. In summary, Metropolis Healthcare Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 291.117 Cr | Rs. 349.789 Cr | Rs. 322.767 Cr | -7.73 % | + 10.87 % |
| Expenses | Rs. 226.27 Cr | Rs. 259.91 Cr | Rs. 250.76 Cr | -3.52 % | + 10.82 % |
| Operating Profit | Rs. 64.85 Cr | Rs. 89.88 Cr | Rs. 72.01 Cr | -19.88 % | + 11.04 % |
| Net Profit | Rs. 27.29 Cr | Rs. 46.7 Cr | Rs. 31.48 Cr | -32.59 % | + 15.35 % |
| EPS in Rs | Rs. 5.28 | Rs. 9.03 | Rs. 6.09 | -32.56 % | + 15.34 % |
In reviewing Metropolis Healthcare Limited’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 10.87 % year-on-year growth, although there was a slight dip of -7.73 % from the previous quarter. Expenses rose by 10.82 % compared to the previous year, with a decrease of -3.52 % quarter-on-quarter. Operating Profit surged by 11.04 % annually, and saw a -19.88 % decrease from the last quarter.
Net Profit showed yearly increase of 15.35 %, and experienced a -32.59 % decrease from the previous quarter. Earnings Per Share (EPS) rose by 15.34 % annually, however dipped by -32.56 % compared to the last quarter. In essence, while Metropolis Healthcare Limited exhibits strong annual growth indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/LGBBROSLTD.png)
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/GOODRICKE.png)
